CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop novel therapies for age-related macular degeneration by targeting retinal circuitry. By modifying rod photoreceptors and horizontal cells, the goal is to restore vision in patients with advanced degeneration, enhancing their ability to see in daylight conditions.
In industrialized countries, age-related macular degeneration (AMD) is the leading cause of untreatable blindness.
In addition to age-related disease, there are also inherited forms of macular degeneration, such as juvenile-onset Stargardt disease.
These conditions, for which there are currently no effective treatments, involve the loss of photoreceptors in the central retina, where a high cone photoreceptor density is responsible for effecting high resolution vision.
We recently discovered that…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, London
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
